-
Sandra
Darkin-Rattray,
A.
Gurnett,
Robert
Myers,
P.
Dulski,
Tami
Crumley,
J.
Allocco,
Christine
Cannova,
P.
Meinke,
S.
Colletti,
M.
Bednarek,
Sheo
Singh,
M.
Goetz,
A.
Dombrowski,
J.
Polishook,
D.
Schmatz
(1996)
Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
Proceedings of the National Academy of Sciences of the United States of America, 93 23
-
P.
Bali,
M.
Pranpat,
J.
Bradner,
M.
Balasis,
W.
Fiskus,
F.
Guo,
K.
Rocha,
S.
Kumaraswamy,
S.
Boyapalle,
P.
Atadja,
E.
Seto,
K.
Bhalla
(2005)
INHIBITION OF HISTONE DEACETYLASE 6 ACETYLATES AND DISRUPTS THE CHAPERONE FUNCTION OF HEAT SHOCK PROTEIN 90: A NOVEL BASIS OF ANTILEUKEMIA ACTIVITY OF HISTONE DEACETYLASE INHIBITORS
-
Ajay
Jain
(2008)
Bias, reporting, and sharing: computational evaluations of docking methods
Journal of Computer-Aided Molecular Design, 22
-
R.
Waller,
Michael
Reed,
A.
Cowman,
G.
McFadden
(2000)
Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway
The EMBO Journal, 19
-
S.
Matalon,
T.
Rasmussen,
C.
Dinarello
(2011)
Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir
Molecular Medicine, 17
-
M.
Joshi,
David
Lin,
C.
Pei,
N.
Goldman,
H.
Fujioka,
M.
Aikawa,
C.
Syin
(1999)
Molecular cloning and nuclear localization of a histone deacetylase homologue in Plasmodium falciparum.
Molecular and biochemical parasitology, 99 1
-
Julia
Wagner,
B.
Hackanson,
M.
Lübbert,
M.
Jung
(2010)
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Clinical Epigenetics, 1
-
K.
Andrews,
K.
Andrews,
T.
Tran,
A.
Lucke,
Pia
Kahnberg,
G.
Le,
G.
Boyle,
D.
Gardiner,
T.
Skinner-Adams,
T.
Skinner-Adams,
D.
Fairlie
(2008)
Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues
Antimicrobial Agents and Chemotherapy, 52
-
Milos
Dokmanovic,
Cathy
Clarke,
P.
Marks
(2007)
Histone Deacetylase Inhibitors: Overview and Perspectives
Molecular Cancer Research, 5
-
W.
Yong,
B.
Goh,
R.
Soo,
H.
Toh,
K.
Ethirajulu,
J.
Wood,
V.
Novotny‐Diermayr,
S.
Lee,
W.
Yeo,
D.
Chan,
D.
Lim,
E.
Seah,
R.
Lim,
J.
Zhu
(2011)
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology, 22 11
-
G.
Dow,
Yufeng
Chen,
K.
Andrews,
Diana
Caridha,
L.
Gerena,
M.
Gettayacamin,
Jacob
Johnson,
Qigui
Li,
V.
Meléndez,
N.
Obaldía,
T.
Tran,
A.
Kozikowski
(2008)
Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors
Antimicrobial Agents and Chemotherapy, 52
-
M.
Finnin,
Jill
Donigian,
Alona
Cohen,
V.
Richon,
R.
Rifkind,
P.
Marks,
R.
Breslow,
N.
Pavletich
(1999)
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Nature, 401
-
J.
Marfurt,
F.
Chalfein,
Pak
Prayoga,
Frans
Wabiser,
E.
Kenangalem,
K.
Piera,
D.
Fairlie,
E.
Tjitra,
N.
Anstey,
K.
Andrews,
R.
Price
(2010)
Ex Vivo Activity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates of Plasmodium falciparum and P. vivax
Antimicrobial Agents and Chemotherapy, 55
-
P.
Marks
(2010)
The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
Expert Opinion on Investigational Drugs, 19
-
R.
Nagel,
C.
Raventós,
H.
Tanowitz,
M.
Wittner
(1980)
FALCIPARUM IN VITRO
-
Anja
Schmidt-Christensen,
Angelika
Sturm,
S.
Horstmann,
V.
Heussler
(2008)
Expression and processing of Plasmodium berghei SERA3 during liver stages
Cellular Microbiology, 10
-
K.
Andrews,
D.
Fairlie,
P.
Madala,
J.
Ray,
D.
Wyatt,
Petrina
Hilton,
Lewis
Melville,
Lynette
Beattie,
D.
Gardiner,
R.
Reid,
Martin
Stoermer,
T.
Skinner-Adams,
C.
Berry,
J.
McCarthy
(2006)
Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria
Antimicrobial Agents and Chemotherapy, 50
-
S.
Altschul,
W.
Gish,
W.
Miller,
E.
Myers,
D.
Lipman
(1990)
Basic local alignment search tool.
Journal of molecular biology, 215 3
-
J.
Philpott,
J.
Keystone
(1987)
Severe falciparum malaria.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 137 2
-
S.
Sarr,
S.
Perrotey,
I.
Fall,
S.
Ennahar,
Minjie
Zhao,
Y.
Diop,
E.
Candolfi,
E.
Marchioni
(2011)
Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity
Malaria Journal, 10
-
A.
Dondorp,
F.
Nosten,
P.
Yi,
D.
Das,
A.
Phyo,
J.
Tarning,
K.
Lwin.,
F.
Ariey,
Warunee
Hanpithakpong,
Sue
Lee,
P.
Ringwald,
K.
Silamut,
M.
Imwong,
K.
Chotivanich,
Pharath
Lim,
T.
Herdman,
S.
An,
S.
Yeung,
P.
Singhasivanon,
N.
Day,
N.
Lindegårdh,
D.
Socheat,
N.
White
(2009)
Artemisinin resistance in Plasmodium falciparum malaria.
The New England journal of medicine, 361 5
-
B.
Pradines,
M.
Mamfoumbi,
A.
Tall,
C.
Sokhna,
J.
Koeck,
T.
Fusai,
J.
Mosnier,
E.
Czarnecki,
A.
Spiegel,
J.
Trape,
M.
Kombila,
C.
Rogier
(2006)
In Vitro Activity of Tafenoquine against the Asexual Blood Stages of Plasmodium falciparum Isolates from Gabon, Senegal, and Djibouti
Antimicrobial Agents and Chemotherapy, 50
-
C.
Canfield,
M.
Pudney,
W.
Gutteridge
(1995)
Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.
Experimental parasitology, 80 3
-
K.
Andrews,
A.
Haque,
Malcolm
Jones
(2012)
HDAC inhibitors in parasitic diseases
Immunology and Cell Biology, 90
-
Albiruni
Razak,
S.
Hotte,
Lillian
Siu,
E.
Chen,
H.
Hirte,
J.
Powers,
W.
Walsh,
Lee-Anne
Stayner,
Anne
Laughlin,
V.
Novotny‐Diermayr,
J.
Zhu,
Elizabeth
Eisenhauer
(2011)
Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
British Journal of Cancer, 104
-
K.
Andrews,
T.
Tran,
Nicole
Wheatley,
D.
Fairlie
(2009)
Targeting histone deacetylase inhibitors for anti-malarial therapy.
Current topics in medicinal chemistry, 9 3
-
M.
Glozak,
N.
Sengupta,
Xiaohong
Zhang,
E.
Seto
(2005)
Acetylation and deacetylation of non-histone proteins.
Gene, 363
-
H.
Berman,
Tammy
Battistuz,
T.
Bhat,
Wolfgang
Bluhm,
Philip
Bourne,
K.
Burkhardt,
Zukang
Feng,
G.
Gilliland,
L.
Iype,
Shri
Jain,
Phoebe
Fagan,
Jessica
Marvin,
David
Padilla,
V.
Ravichandran,
B.
Schneider,
N.
Thanki,
H.
Weissig,
J.
Westbrook,
C.
Zardecki
Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank
-
Sachel
Mok,
M.
Imwong,
M.
Mackinnon,
J.
Sim,
R.
Ramadoss,
P.
Yi,
M.
Mayxay,
K.
Chotivanich,
Kek-Yee
Liong,
B.
Russell,
D.
Socheat,
P.
Newton,
N.
Day,
N.
White,
P.
Preiser,
F.
Nosten,
A.
Dondorp,
Zbynek
Bozdech
(2011)
Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription
BMC Genomics, 12
-
F.
Amante,
A.
Stanley,
L.
Randall,
Yonghong
Zhou,
A.
Haque,
Karli
McSweeney,
A.
Waters,
C.
Janse,
M.
Good,
G.
Hill,
C.
Engwerda
(2007)
A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.
The American journal of pathology, 171 2
-
M.
Bates,
S.
Meshnick,
C.
Sigler,
P.
Leland,
M.
Hollingdale
(1990)
In vitro effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghei.
The American journal of tropical medicine and hygiene, 42 6
-
B.
Chaal,
Archna
Gupta,
Brigitta
Wastuwidyaningtyas,
Y.
Luah,
Zbynek
Bozdech
(2010)
Histone Deacetylases Play a Major Role in the Transcriptional Regulation of the Plasmodium falciparum Life Cycle
PLoS Pathogens, 6
-
S.
Agbor-Enoh,
C.
Seudieu,
E.
Davidson,
A.
Dritschilo,
M.
Jung
(2009)
Novel Inhibitor of Plasmodium Histone Deacetylase That Cures P. berghei-Infected Mice
Antimicrobial Agents and Chemotherapy, 53
-
Christopher
Tonkin,
C.
Carret,
M.
Duraisingh,
Till
Voss,
S.
Ralph,
M.
Hommel,
M.
Duffy,
L.
Silva,
A.
Scherf,
A.
Ivens,
T.
Speed,
J.
Beeson,
A.
Cowman
(2009)
Sir2 Paralogues Cooperate to Regulate Virulence Genes and Antigenic Variation in Plasmodium falciparum
PLoS Biology, 7
-
Morris
Berenbaum
(1978)
A method for testing for synergy with any number of agents.
The Journal of infectious diseases, 137 2
-
J.
Vennerstrom,
Edwin
Nuzum,
Robert
Miller,
A.
Dorn,
L.
Gerena,
P.
Dande,
W.
Ellis,
R.
Ridley,
W.
Milhous
(1999)
8-Aminoquinolines Active against Blood Stage Plasmodium falciparum In Vitro Inhibit Hematin Polymerization
Antimicrobial Agents and Chemotherapy, 43
-
S.
Minucci,
P.
Pelicci
(2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Nature Reviews Cancer, 6
-
D.
Eisenberg,
R.
Lüthy,
J.
Bowie
(1997)
VERIFY3D: assessment of protein models with three-dimensional profiles.
Methods in enzymology, 277
-
J.
Somoza,
R.
Skene,
B.
Katz,
C.
Mol,
J.
Ho,
A.
Jennings,
C.
Luong,
A.
Arvai,
J.
Buggy,
Ellen
Chi,
Jie
Tang,
Biching
Sang,
E.
Verner,
R.
Wynands,
E.
Leahy,
D.
Dougan,
G.
Snell,
M.
Navre,
M.
Knuth,
R.
Swanson,
D.
McRee,
L.
Tari
(2004)
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.
Structure, 12 7
-
Lin
Gao,
M.
Cueto,
F.
Asselbergs,
P.
Atadja
(2002)
Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family*
The Journal of Biological Chemistry, 277
-
Guangan
Hu,
Ana
Cabrera,
M.
Kono,
Sachel
Mok,
B.
Chaal,
Silvia
Haase,
K.
Engelberg,
S.
Cheemadan,
T.
Spielmann,
P.
Preiser,
T.
Gilberger,
Zbynek
Bozdech
(2010)
Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum
Nature Biotechnology, 28
-
L.
Sanderson,
G.
Taylor,
E.
Aboagye,
John-Patrick
Alao,
J.
Latigo,
R.
Coombes,
D.
Vigushin
(2004)
PLASMA PHARMACOKINETICS AND METABOLISM OF THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A AFTER INTRAPERITONEAL ADMINISTRATION TO MICE
Drug Metabolism and Disposition, 32
-
C.
Aurrecoechea,
John
Brestelli,
B.
Brunk,
Jennifer
Dommer,
S.
Fischer,
Bindu
Gajria,
Xin
Gao,
A.
Gingle,
G.
Grant,
O.
Harb,
Mark
Heiges,
F.
Innamorato,
John
Iodice,
J.
Kissinger,
Eileen
Kraemer,
Wei
Li,
John
Miller,
V.
Nayak,
Cary
Pennington,
D.
Pinney,
D.
Roos,
Chris
Ross,
C.
Stoeckert,
Charles
Treatman,
Haiming
Wang
(2008)
PlasmoDB: a functional genomic database for malaria parasites
Nucleic Acids Research, 37
-
Christopher,
A.
Lipinski,
Beryl,
W.
Dominy,
Paul,
J.
Feeney
(2001)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
Advanced drug delivery reviews, 46 1-3
-
C.
Grozinger,
S.
Schreiber
(2002)
Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.
Chemistry & biology, 9 1
-
A.
Berendt,
G.D.H.
Tumer,
C.
Newbold
(1994)
Cerebral malaria: the sequestration hypothesis.
Parasitology today, 10 10
-
J.
Beumer,
H.
Tawbi
(2010)
Role of histone deacetylases and their inhibitors in cancer biology and treatment.
Current clinical pharmacology, 5 3
-
W.
Huber,
J.
Koella
(1993)
A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites.
Acta tropica, 55 4
-
J.
Thompson,
D.
Higgins,
T.
Gibson
(1994)
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic acids research, 22 22
-
L.
Freitas-Junior,
R.
Hernández-Rivas,
S.
Ralph,
D.
Montiel-Condado,
Omar
Ruvalcaba-Salazar,
Ana
Rojas-Meza,
Liliana
Mancio-Silva,
Ricardo
Leal-Silvestre,
Alisson
Gontijo,
S.
Shorte,
A.
Scherf
(2005)
Telomeric Heterochromatin Propagation and Histone Acetylation Control Mutually Exclusive Expression of Antigenic Variation Genes in Malaria Parasites
Cell, 121
-
R.
Jayaraman,
V.
Reddy,
Mohammed
Pasha,
Haishan
Wang,
K.
Sangthongpitag,
P.
Yeo,
Chang
Hu,
Xiaofeng
Wu,
Liu
Xin,
E.
Goh,
Lee
New,
K.
Ethirajulu
(2011)
Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics
Drug Metabolism and Disposition, 39
-
S.
Satpathy,
N.
Mohanty,
P.
Nanda,
G.
Samal
(2004)
Severe falciparum malaria
The Indian Journal of Pediatrics, 71
-
Katherine
Andrews,
Anna
Walduck,
Michael
Kelso,
David
Fairlie,
Allan
Saul,
Peter
Parsons
(2000)
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.
International journal for parasitology, 30 6
-
G.
Ortore,
F.
Colo,
A.
Martinelli
(2009)
Docking of Hydroxamic Acids into HDAC1 and HDAC8: A Rationalization of Activity Trends and Selectivities
Journal of chemical information and modeling, 49 12
-
V.
Kekatpure,
A.
Dannenberg,
K.
Subbaramaiah
(2009)
HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling*
Journal of Biological Chemistry, 284
-
T.
Skinner-Adams,
T.
Skinner-Adams,
K.
Andrews,
Lewis
Melville,
J.
McCarthy,
D.
Gardiner
(2006)
Synergistic Interactions of the Antiretroviral Protease Inhibitors Saquinavir and Ritonavir with Chloroquine and Mefloquine against Plasmodium falciparum In Vitro
Antimicrobial Agents and Chemotherapy, 51
-
Haishan
Wang,
Niefang
Yu,
Dizhong
Chen,
K.
Lee,
Pek-Ling
Lye,
J.
Chang,
Weiping
Deng,
M.
Ng,
Ting-Feng
Lu,
M.
Khoo,
Anders
Poulsen,
K.
Sangthongpitag,
Xiaofeng
Wu,
Changyong
Hu,
K.
Goh,
Xukun
Wang,
L.
Fang,
Kay
Goh,
H.
Khng,
Siok
Goh,
P.
Yeo,
Xin
Liu,
Zahid
Bonday,
J.
Wood,
B.
Dymock,
E.
Kantharaj,
E.
Sun
(2011)
Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile.
Journal of medicinal chemistry, 54 13
-
J.
Bressi,
A.
Jennings,
R.
Skene,
Yiqin
Wu,
Robert
Melkus,
R.
Jong,
Shawn
O’Connell,
C.
Grimshaw,
M.
Navre,
A.
Gangloff
(2010)
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides.
Bioorganic & medicinal chemistry letters, 20 10
-
A.
Sali,
T.
Blundell
(1993)
Comparative protein modelling by satisfaction of spatial restraints.
Journal of molecular biology, 234 3
-
(2009)
Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 69:1911–1934
-
V.
Novotny‐Diermayr,
K.
Sangthongpitag,
Changyong
Hu,
Xiaofeng
Wu,
N.
Sausgruber,
P.
Yeo,
Gediminas
Greicius,
S.
Pettersson,
A.
Liang,
Y.
Loh,
Zahid
Bonday,
K.
Goh,
H.
Hentze,
S.
Hart,
Haishan
Wang,
K.
Ethirajulu,
J.
Wood
(2010)
SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
Molecular Cancer Therapeutics, 9
-
Ginger
Lehrman,
Ian
Hogue,
S.
Palmer,
C.
Jennings,
C.
Spina,
A.
Wiegand,
A.
Landay,
R.
Coombs,
D.
Richman,
J.
Mellors,
J.
Coffin,
R.
Bosch,
D.
Margolis
(2005)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
The Lancet, 366
-
Min-Yi
Shen,
A.
Sali
(2006)
Statistical potential for assessment and prediction of protein structures
Protein Science, 15
-
S.
Crabb,
M.
Howell,
Helen
Rogers,
M.
Ishfaq,
A.
Yurek-George,
Krystle
Carey,
B.
Pickering,
P.
East,
R.
Mitter,
Satoko
Maeda,
Peter
Johnson,
P.
Townsend,
K.
Shin‐ya,
Minoru
Yoshida,
A.
Ganesan,
G.
Packham
(2008)
Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A.
Biochemical pharmacology, 76 4
-
(2009)
Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum
-
S.
Nair,
C.
Brooks,
C.
Goodman,
Angelika
Strurm,
G.
McFadden,
S.
Sundriyal,
J.
Anglin,
Yongcheng
Song,
S.
Moreno,
B.
Striepen
(2011)
Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii
The Journal of Experimental Medicine, 208
-
M.
Duraisingh,
Till
Voss,
Allison
Marty,
M.
Duffy,
R.
Good,
Jenn
Thompson,
L.
Freitas-Junior,
A.
Scherf,
B.
Crabb,
A.
Cowman
(2005)
Heterochromatin Silencing and Locus Repositioning Linked to Regulation of Virulence Genes in Plasmodium falciparum
Cell, 121
-
B.
Cairns
(2001)
Emerging roles for chromatin remodeling in cancer biology.
Trends in cell biology, 11 11